Medical Devices Startups

IMAI develops 3D histology technology for early and accurate diagnosis of cancer to improve therapeutic outcomes and patient care in oncology.

1 investor

imaware operates a white-label biomarker testing platform that enables healthcare partners to offer personalized health data and testing services to consumers across 50 U.S. states. The platform integrates with existing healthcare systems and provides HIPAA-compliant results, analytics, and support for virtual care.

1 investor

Imbed Biosciences is a medical device company that develops SAMatrix, an ultra-thin, fully synthetic bioresorbable wound matrix that integrates antimicrobial silver and non-opioid pain agents (lidocaine) for treating chronic and acute wounds such as ulcers, surgical, traumatic, and burn wounds. Its product portfolio includes Surgaflex, Pelashield, and Microlyte, along with PainGuard variants.

1 investor

iMediSync develops AI and machine learning-based diagnostic platforms for neuropsychiatric and brain disorders, including tools for early dementia detection and Parkinson's disease classification. The company serves healthcare providers and institutions with FDA-approved software medical devices and wearable technology.

1 investor

An enterprise that develops and commercializes biomedical materials and biopharmaceutical products, including Class III and Class II medical devices, dermal fillers, facial threads, and proteins/peptides for medical aesthetics, dermatology, surgery, metabolic disease, and professional skincare.

1 investor

ImmuneSpecs uses immunopeptidomics (MAPPs) technology to identify peptides presented by MHC molecules, enabling precise mapping of T cell epitopes in biotherapeutics and validation of immunotherapy targets. The company serves biopharmaceutical organizations seeking advanced antigen presentation analysis.

1 investor

Immunicom is a biotech company developing immunotherapies based on its Immunopheresis platform, a blood-filtering device that works external to the body to treat cancer and inflammatory, cardiovascular, renal, and autoimmune diseases. Its initial focus is immuno-oncology, with CE Mark approval in Europe for advanced triple-negative breast cancer and multiple ongoing clinical trials.

1 investor

Immunique is a science-based biotech company developing cell therapies that restore balance in the immune system to treat disease and support long-term patient recovery. Its research focuses on immune cell function and is aimed at extending healthy lifespan through clinical- and data-driven treatment strategies.

1 investor

Immunocodex develops lipid nanoparticle mRNA-based therapies targeting dendritic cells to induce immune tolerance for the treatment of autoimmune diseases. The company employs a precision approach that aims to re-program immune cells to suppress inflammatory responses while avoiding broad immunosuppression.

1 investor

Yicura is a clinical-stage biotechnology company developing DNA medicines and antibody immunotherapies for cancer, inflammatory, and infectious diseases using proprietary vaccine and antibody platforms.

1 investor

ImmunoScape is a Singapore-based biotechnology company developing high-throughput immune profiling and therapeutic T cell receptor discovery platforms for immunotherapy and cancer treatment. The company was spun off from Singapore's A*STAR research institute and serves the immunotherapy and oncology sectors.

1 investor

ImmunoStep produces monoclonal antibodies for research use, including recombinant antibodies that target specific T-cell receptors for flow cytometry applications in immunology research.

1 investor

Immunovant is a clinical-stage immunology company developing targeted therapies based on anti-FcRn technology for people with autoimmune diseases.

1 investor

Impact Medical Innovations develops diagnostic technologies for detecting ovarian and prostate cancer, with a focus on creating affordable, accessible point-of-care solutions to address global healthcare gaps.

1 investor

ImpediMed develops bioimpedance measuring devices and analysis software used to assess fluid status and body composition for medical and veterinary applications. Its product line includes clinical measurement devices and companion analysis software.

1 investor

Implanet designs and manufactures spinal implants for surgeons specializing in spine surgery, operating as an international publicly listed medical device company with presence in 42 countries.

1 investor

Implican is developing a patented anastomotic device that uses two compression rings to fixate bowel walls during colorectal surgery, aiming to achieve primary wound healing and reduce anastomotic leakage. The device targets surgeons treating colorectal cancer patients as an alternative to circular staplers, and is in preclinical/clinical testing.

1 investor

Implicity offers a device-agnostic SaaS platform for remote monitoring of cardiac implantable electronic devices (CIEDs), using FDA-cleared AI to centralize device data, filter alerts, and automate billing and reporting. It serves cardiac care teams, nurses, technicians, and administrative/billing staff at cardiology practices and hospitals.

1 investor

Impulse Dynamics develops implantable medical device technology for cardiac care, with a background in biomedical research and implantable cardiac electronics. The company operates in the cardiovascular medical device industry.

1 investor

Impulse Biomed is a South African medical device company that develops affordable healthcare products, including the ZiBiPen reloadable adrenaline auto-injector and the Easy Squeezy inhaler attachment for asthma and allergy care. It focuses on making life-saving medical technologies accessible in under-resourced settings.

1 investor

IMS supplies non-pharmaceutical medical consumables, equipment, and facility essentials to veterinary practices, human healthcare providers, laboratories, and workplaces. The UK-based company sources both industry-leading and alternative brands at competitive prices, offering next-day delivery.

1 investor

Immunic is a clinical-stage biopharmaceutical company developing oral small molecule treatments for neurologic and autoimmune diseases with unmet medical needs.

1 investor

A clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for oncology and autoimmune diseases, targeting off-the-shelf and scalable treatments to improve patient access.

1 investor

Nuh develops medical imaging and diagnostic devices, including fluorescence endoscopes, dual image sensor systems, parathyroid exoscopes, and surgical lasers, along with a range of patient monitoring and diagnostic instruments. Its technology portfolio spans endoscopy, photodynamic therapy, imaging cameras, and surgical robotics, supported by a patent and design portfolio across the U.S., Korea, and China.

1 investor